Capital Impact Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Capital Impact Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,922	Closed	-$2.32M	–	141
2017 Q3	$2.32M	Hold	12,922	–	–	1.04%	11
2017 Q2	$1.34M	Sell	12,922 -4,950	-28%	-$404K	0.61%	64
2017 Q1	$1.4M	Buy	+17,872	New	+$1.11M	0.56%	100
2016 Q1	–	Sell	-5,053	Closed	-$311K	–	260
2015 Q4	$311K	Hold	5,053	–	–	0.15%	240
2015 Q3	$281K	Hold	5,053	–	–	0.14%	220
2015 Q2	$308K	Hold	5,053	–	–	0.14%	232
2015 Q1	$291K	Buy	+5,053	New	+$339K	0.13%	248

Capital Impact Advisors's KITE Position: Q4 2017 in Review

Capital Impact Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 12,922 shares — an estimated $2.32M sold.

Capital Impact Advisors first reported a position in KITE in Q1 2015 and held it in 7 quarters. The position peaked at $2.32M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Capital Impact Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Capital Impact Advisors sold 12,922 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.32M.
Capital Impact Advisors first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 7 quarters.
Capital Impact Advisors's Kite Pharma, Inc. position peaked at $2.32M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Capital Impact Advisors's 13F filing for Q4 2017, filed 16 Jan 2018.